These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 26146084)
1. Recurrent Fusion Genes in Gastric Cancer: CLDN18-ARHGAP26 Induces Loss of Epithelial Integrity. Yao F; Kausalya JP; Sia YY; Teo AS; Lee WH; Ong AG; Zhang Z; Tan JH; Li G; Bertrand D; Liu X; Poh HM; Guan P; Zhu F; Pathiraja TN; Ariyaratne PN; Rao J; Woo XY; Cai S; Mulawadi FH; Poh WT; Veeravalli L; Chan CS; Lim SS; Leong ST; Neo SC; Choi PS; Chew EG; Nagarajan N; Jacques PÉ; So JB; Ruan X; Yeoh KG; Tan P; Sung WK; Hunziker W; Ruan Y; Hillmer AM Cell Rep; 2015 Jul; 12(2):272-85. PubMed ID: 26146084 [TBL] [Abstract][Full Text] [Related]
2. Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer. Zhang F; Sahu V; Peng K; Wang Y; Li T; Bala P; Aitymbayev D; Sahgal P; Schaefer A; Der CJ; Ryeom S; Yoon S; Sethi N; Bass AJ; Zhang H Gut; 2024 Jul; 73(8):1280-1291. PubMed ID: 38621923 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer. Shu Y; Zhang W; Hou Q; Zhao L; Zhang S; Zhou J; Song X; Zhang Y; Jiang D; Chen X; Wang P; Xia X; Liao F; Yin D; Chen X; Zhou X; Zhang D; Yin S; Yang K; Liu J; Fu L; Zhang L; Wang Y; Zhang J; An Y; Cheng H; Zheng B; Sun H; Zhao Y; Wang Y; Xie D; Ouyang L; Wang P; Zhang W; Qiu M; Fu X; Dai L; He G; Yang H; Cheng W; Yang L; Liu B; Li W; Dong B; Zhou Z; Wei Y; Peng Y; Xu H; Hu J Nat Commun; 2018 Jun; 9(1):2447. PubMed ID: 29961079 [TBL] [Abstract][Full Text] [Related]
4. Suppression of BMX-ARHGAP fusion gene inhibits epithelial-mesenchymal transition in gastric cancer cells via RhoA-mediated blockade of JAK/STAT axis. Xu XF; Wang JJ; Ding L; Ye JS; Huang LJ; Tao L; Gao F; Ji Y J Cell Biochem; 2019 Jan; 120(1):439-451. PubMed ID: 30216523 [TBL] [Abstract][Full Text] [Related]
5. Immunotherapies targeting the oncogenic fusion gene CLDN18-ARHGAP in gastric cancer. Wang Y; Wang H; Shi T; Song X; Zhang X; Zhang Y; Wang X; Che K; Luo Y; Yu L; Liu B; Wei J EMBO Mol Med; 2024 Sep; 16(9):2170-2187. PubMed ID: 39164472 [TBL] [Abstract][Full Text] [Related]
6. Enrichment of CLDN18-ARHGAP fusion gene in gastric cancers in young adults. Nakayama I; Shinozaki E; Sakata S; Yamamoto N; Fujisaki J; Muramatsu Y; Hirota T; Takeuchi K; Takahashi S; Yamaguchi K; Noda T Cancer Sci; 2019 Apr; 110(4):1352-1363. PubMed ID: 30771244 [TBL] [Abstract][Full Text] [Related]
7. RHOA mutations and CLDN18-ARHGAP fusions in intestinal-type adenocarcinoma with anastomosing glands of the stomach. Hashimoto T; Ogawa R; Tang TY; Yoshida H; Taniguchi H; Katai H; Oda I; Sekine S Mod Pathol; 2019 Apr; 32(4):568-575. PubMed ID: 30425335 [TBL] [Abstract][Full Text] [Related]
8. RhoGAP domain-containing fusions and PPAPDC1A fusions are recurrent and prognostic in diffuse gastric cancer. Yang H; Hong D; Cho SY; Park YS; Ko WR; Kim JH; Hur H; Lee J; Kim SJ; Kwon SY; Lee JH; Park DY; Song KS; Chang H; Ryu MH; Cho KS; Kang JW; Kook MC; Thiessen N; He A; Mungall A; Han SU; Kim HK Nat Commun; 2018 Oct; 9(1):4439. PubMed ID: 30361512 [TBL] [Abstract][Full Text] [Related]
9. Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity. Liu N; Bi F; Pan Y; Sun L; Xue Y; Shi Y; Yao X; Zheng Y; Fan D Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6239-47. PubMed ID: 15448013 [TBL] [Abstract][Full Text] [Related]
10. RhoA, Claudin 18, and c-MET in Gastric Cancer: Clinicopathological Characteristics and Prognostic Significance in Curative Resected Patients. Pereira MA; Ramos MFKP; Dias AR; Cardili L; Ribeiro RRE; de Castria TB; Zilberstein B; Nahas SC; Ribeiro U; de Mello ES Med Sci (Basel); 2021 Dec; 10(1):. PubMed ID: 35076580 [No Abstract] [Full Text] [Related]
11. Clathrin-mediated endocytosis regulates occludin, and not focal adhesion, distribution during epithelial wound healing. Fletcher SJ; Poulter NS; Haining EJ; Rappoport JZ Biol Cell; 2012 Apr; 104(4):238-56. PubMed ID: 22187938 [TBL] [Abstract][Full Text] [Related]
12. Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study. Dottermusch M; Krüger S; Behrens HM; Halske C; Röcken C Virchows Arch; 2019 Nov; 475(5):563-571. PubMed ID: 31332522 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the expression and genetic alteration of CLDN18 in gastric cancer. Li J; Zhang Y; Hu D; Gong T; Xu R; Gao J Aging (Albany NY); 2020 Jul; 12(14):14271-14284. PubMed ID: 32668412 [TBL] [Abstract][Full Text] [Related]
14. ARHGAP-RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer. Komatsu M; Ichikawa H; Chiwaki F; Sakamoto H; Komatsuzaki R; Asaumi M; Tsunoyama K; Fukagawa T; Matsushita H; Boku N; Matsusaki K; Takeshita F; Yoshida T; Sasaki H Oncogene; 2022 Oct; 41(43):4779-4794. PubMed ID: 36127398 [TBL] [Abstract][Full Text] [Related]
15. The RhoA pathway mediates MMP-2 and MMP-9-independent invasive behavior in a triple-negative breast cancer cell line. Fagan-Solis KD; Schneider SS; Pentecost BT; Bentley BA; Otis CN; Gierthy JF; Arcaro KF J Cell Biochem; 2013 Jun; 114(6):1385-94. PubMed ID: 23255405 [TBL] [Abstract][Full Text] [Related]
16. HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition. Wu X; Chen H; Parker B; Rubin E; Zhu T; Lee JS; Argani P; Sukumar S Cancer Res; 2006 Oct; 66(19):9527-34. PubMed ID: 17018609 [TBL] [Abstract][Full Text] [Related]